Trial record 18 of 91 for: "Brain Diseases" AND "Multiple System Atrophy"
Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02064166|
Recruitment Status : Completed
First Posted : February 17, 2014
Results First Posted : November 22, 2018
Last Update Posted : November 22, 2018
Information provided by (Responsible Party):
Peter Novak, University of Massachusetts, Worcester
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Multiple System Atrophy
Drug: Intranasal Insulin